This week on Contemporary OB/GYN: January 2 to January 6

Article

A look at what's coming to Contemporary OB/GYN this week.

Early pregnancy complications after frozen-thawed embryo transfer

Women who underwent a frozen-thawed embryo transfer (FET) for assisted reproductive technology (ART) treatment were nearly twice as likely to experience bleeding or miscarriage in the first trimester with hormone replacement cycles (HRC-FET) compared to natural cycles (NC-FET), according to a retrospective cohort study published in the European Journal of Obstetrics & Gynecology and Reproductive Biology.

A fresh start

As the holiday season leaves as quickly as it arrived, we are left with a clean slate for the year. This fresh opportunity promises a mountain of possibilities; however, the New Year can also be intimidating. From the challenge of getting back into the swing of things post holiday to determining what your goals will be for the year, many things can make the beginning of the New Year daunting.

Frequency of condomless sex among women using reversible methods of contraception

A substudy of the Evidence for Contraceptive Options and HIV Outcomes (ECHO) trial, which compared three highly effective, reversible methods of contraception, concluded that women assigned either a copper intrauterine device (Cu-IUD) or the levonorgestrel (LNG) implant may have had condomless sex more frequently than women assigned to intramuscular depo-medroxyprogesterone acetate (DMPA-IM).

Chromosomal abnormalities do not impact ART outcomes

Chromosomal abnormalities in infertile couples who use assisted reproductive technology (ART) do not appear to impact cumulative clinical pregnancy or live-birth rates, according to a study published in the Annals of Medicine. Although clinicians should offer preimplantation genetic testing (PGT) to prospective parents with chromosomal rearrangements, authors add, no evidence supports its universal use in this population.

Check back soon for additional updates!

Recent Videos
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
How AI is revolutionizing breast cancer detection | Image Credit: simonmed.com
Understanding cardiovascular risk factors in women | Image Credit: cedars-sinai.org.
Christie Hilton, DO, discusses breast cancer management | Image Credit: findcare.ahn.org
Updated FLUBLOK label expands influenza vaccine options for pregnant women | Image Credit: mass-vaccination-resources.org
Sheryl Kingsberg, PhD: Psychedelic RE104 for postpartum depression
Mammograms may reveal hidden cardiovascular risks, study finds | Image Credit: providers.ucsd.edu
Erika Hamilton highlights emerging breast cancer trends and advances in treatment | Image Credit: sarahcannon.com
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
© 2024 MJH Life Sciences

All rights reserved.